Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Dr. Awatef Sassi, Faculty of medicine of sousse, Tunisia

Dr. Awatef Sassi 🧬🔬 is a distinguished postdoctoral researcher at the Faculty of Medicine of Sousse, specializing in cardiovascular and metabolic research. She earned her Ph.D. in Biological Sciences (2018) from the Faculty of Science of Bizerte, following a Master’s in Vascular Diseases Biology (2011) and a Medical Biotechnology degree (2008). Dr. Sassi has contributed significantly to scientific advancements, securing a patent on anti-hypertensive properties of Rosmarinus officinalis and publishing in high-impact journals. She is actively involved in mentoring medical theses and conducting innovative research in biophysics and applied toxicology. 🌿📊

Publication Profile

Orcid

Education

Dr. Awatef Sassi is a distinguished scholar in biological sciences 🧬, biotechnology 🏥, and vascular diseases ❤️. With a Ph.D. in Biological Sciences 🎓, a Master’s in Vascular Disease Biology, and a Medical Biotechnology degree, she has demonstrated an unwavering commitment to scientific research 🔬. Her extensive expertise spans innovative biotechnological applications and advancements in vascular health, contributing significantly to the medical and scientific communities. Dr. Sassi’s dedication to excellence and groundbreaking research continues to shape the future of biotechnology and vascular medicine, making her a respected figure in the field 🌟.

Experience 

Dr. Awatef Sassi’s postdoctoral research at the Faculty of Medicine in Sousse 🏥 has focused on cardio-pulmonary interactions 💓💨 and biophysics ⚛️, making significant contributions to biomedical sciences. As a dedicated mentor, she has supervised multiple medical theses 📚, showcasing her leadership in academia. Her patented innovation 🏅 on the antihypertensive activity of Rosmarinus officinalis 🌿 (TN 2023/0143) highlights groundbreaking research with potential clinical impact in hypertension treatment 💊. Through her pioneering work, Dr. Sassi continues to advance medical science, bridging research and practical healthcare solutions for improved cardiovascular health ❤️.

Professional Development

Dr. Awatef Sassi is a dedicated educator and researcher 🎓🔬, with extensive experience as a lecturer in analytical chemistry ⚗️. Her involvement in postgraduate training 📚 has strengthened expertise in HPLC/UPLC 💉, mass spectrometry 🧪, and data analysis (SPSS) 📊. Through her teaching and mentorship, she equips students and researchers with essential analytical and computational skills, fostering scientific excellence. Dr. Sassi’s commitment to professional development ensures that future scientists gain hands-on experience in advanced laboratory techniques, making a lasting impact in biotechnology, pharmacology, and medical sciences 🏥🌿.

Research Focus

Dr. Awatef Sassi’s research primarily focuses on phytomedicine 🌿, clinical nutrition 🥗, cardiovascular health ❤️, and pharmaceutical sciences 💊. Her work explores the therapeutic potential of medicinal plants like Rosmarinus officinalis and Nitraria retusa for conditions such as hypertension, obesity, and lipid disorders. Additionally, she has contributed to cardiovascular interventions 🏥, dermatological formulations, and transfusion medicine 🩸. Her studies include randomized clinical trials, pilot studies, and formulation research, highlighting her interdisciplinary approach to natural product-based therapy and clinical pharmacology. Her work significantly impacts personalized medicine, preventive healthcare, and alternative treatment strategies.

Publication Top Notes

The Effect of Rosmarinus officinalis L Infusion Supplementation on Blood Pressure Among Healthy Volunteers and Grade 1 Hypertensive Patients

Antiobesity and Hypolipidemic Potential of Nitraria retusa Extract in Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Exploring the Effects of Short-Term Daily Intake of Nitraria retusa Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults

Distal radial approach versus conventional radial approach: a comparative study of feasibility and safety

Formulation and evaluation of topical halofuginone gel using a novel <I>ex vivo</i> model

RHD genotyping and its implication in transfusion practice

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dr Dipanjan Karati, Techno India University, West Bengal, India

Dr. Dipanjan Karati is an Assistant Professor at Techno India University, West Bengal, with expertise in pharmaceutical chemistry. He holds a M. Pharm (2021) from Bharati Vidyapeeth University and a B. Pharm (2019) from MAKAUT, both with distinction. His research focuses on neurodegenerative diseases and antimicrobial agents, with several publications in prestigious journals. Dr. Karati has actively participated in numerous seminars, webinars, and workshops. He is a GPAT 2019 qualifier and has industrial training at Glenmark Pharmaceuticals. He is passionate about academics and research in the field of drug development. 📚💊🧠🔬👨‍🔬

Publication Profile

Google Scholar

Academic Excellence

Dr. Dipanjan Karati is a highly qualified pharmaceutical professional with a strong academic background. He completed his M. Pharm in Pharmaceutical Chemistry from Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, in 2021, securing a first-class distinction with an 8.09 CGPA. Prior to that, he earned his B Pharm from NSHM Knowledge Campus, Kolkata, in 2019, with an outstanding 80.2% (1st class with distinction). Dr. Karati completed his HSC in 2013 with 81.2% and SSC in 2011 with 78.125% from Garh Bhawanipur RP Institution, Howrah. His consistent academic performance highlights his dedication to the pharmaceutical field. 📚💊🎓

Research Project

Dr. Dipanjan Karati’s research focuses on the “In Silico Design, Synthesis, and Evaluation of Novel Schiff Base Congeners as Neurodegenerative and Antimicrobial Agents.” His objective is to design and synthesize innovative pyrimidine derivatives containing a nitrile group and substituted Schiff bases with azomethine groups. These compounds are being explored for their potential in treating neurodegenerative diseases and exhibiting antimicrobial properties. Dr. Karati’s work combines advanced computational techniques and experimental synthesis to develop effective therapeutic agents, aiming to contribute significantly to the fields of neurodegenerative diseases and antimicrobial resistance. 🔬🧠💊🦠💡

Experience

Dr. Dipanjan Karati has an impressive academic and professional background in the pharmaceutical field. He completed his Industrial Training at Glenmark Pharmaceutical Limited from January 9th to 23rd, 2018, gaining valuable industry experience. He served as an Assistant Professor at Gitanjali College of Pharmacy in Lohapur, Birbhum, for one year, contributing to the academic development of students. Currently, Dr. Karati holds the position of Assistant Professor at the School of Pharmacy, TIU, since September 2022, continuing his dedication to education and research. 📚💊👨‍🏫

Achievements and Awards

Dr. Dipanjan Karati achieved a significant milestone by qualifying for the All India Graduate Pharmacy Aptitude Test (GPAT) in 2019, showcasing his dedication and expertise in the field of pharmacy. 🏆📚 This prestigious achievement highlights his academic excellence and potential for contributing to pharmaceutical sciences. 🌟💊 With his strong foundation and passion for research, Dr. Karati is committed to advancing innovations in pharmacy and healthcare. 🚀🔬 His GPAT qualification is a testament to his hard work and determination, inspiring others in the field to strive for academic and professional success. 🌱🎓

Research Focus

Dr. Dipanjan Karati’s research focuses on medicinal chemistry, pharmacognosy, and drug discovery. His studies emphasize exploring bioactive compounds from plants 🌱, such as Ficus racemosa and Zingiber officinale, for their pharmacological properties including anti-inflammatory, anticancer, and antimicrobial activities 🧪🩺. He investigates synthetic scaffolds like pyrazoles and benzimidazoles for designing innovative therapies targeting diseases such as cancer, malaria, and infections 🎯🧬. Dr. Karati also explores bio-responsive polymers for targeted drug delivery and examines natural products like Cordyceps sinensis for therapeutic potential 🍄🔬. His work bridges natural products and modern medicinal approaches, advancing personalized treatments 🌟📖.

Publication Top Notes

Alkylating agents, the road less traversed, changing anticancer therapy

Pyrazole Scaffolds: centrality in anti-inflammatory and antiviral drug design

Exploring the pharmacognostic properties and pharmacological activities of phytocompounds present in Ficus racemosa linn.: A concise review

A molecular insight into pyrazole congeners as antimicrobial, anticancer, and antimalarial agents

Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective

In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation

Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica charantia

 

Ajaz Ahmad| Drug Discovery and Development | Best Researcher Award

Prof. Ajaz Ahmad | Drug Delivery Systems| Best Researcher Award

 King Saud University, Saudi Arabia

Author Profile

🎓Early Academic Pursuits 

Professor Ajaz Ahmad began his distinguished academic journey at the prestigious Hamdard University in New Delhi, India. He earned a Bachelor of Pharmacy (B.Pharm) in 2005, where he demonstrated an early inclination toward pharmaceutical sciences. Continuing his education at the same institution, he completed a Master of Pharmacy (M.Pharm) in 2007, refining his focus on drug delivery and molecular pharmacology. Driven by a passion for research, he pursued a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, which he completed in 2011. His doctoral research laid the foundation for his expertise in drug discovery, pharmacokinetics, and the molecular mechanisms underpinning drug actions.

💼Professional Endeavors 

King Saud University, Saudi Arabia
Prof. Ahmad joined the College of Pharmacy at King Saud University in 2011 as an Assistant Professor in Clinical Pharmacy. Over the next decade, his contributions to research and teaching led to successive promotions—first as an Associate Professor in 2017 and then to his current role as Professor in Clinical Pharmacy in January 2024. At King Saud University, Prof. Ahmad’s role encompasses teaching advanced courses, mentoring postgraduate students, and conducting cutting-edge research in pharmacology and drug development.International Collaborations
Since 2015, Prof. Ahmad has served as a research collaborator with the Mayo Clinic, USA, a testament to his global reputation in pharmaceutical sciences. In 2013, he was appointed an Honorary Research Associate at the University of Hong Kong, further broadening his academic and professional network.Patents and Industry EngagementProf. Ahmad holds a U.S. patent (US20170231925A1) for treating neurovascular complications of diabetes mellitus. This innovation highlights his commitment to bridging the gap between research and practical healthcare applications.

🔬Contributions and Research Focus 

Prof. Ahmad’s research covers a broad spectrum of topics in pharmaceutical sciences, with particular focus areas including:Preclinical Drug Development: He has explored novel therapeutic agents, focusing on their efficacy, safety, and molecular mechanisms.Pharmacokinetics and Drug Metabolism: His work delves into the ADME (absorption, distribution, metabolism, and excretion) properties of drugs, optimizing formulations and dosing regimens.Bioanalytical Method Development: Prof. Ahmad designs and validates analytical methods for drug quantification, ensuring reproducibility and precision.Animal Models for Disease Research: He conducts in vivo studies simulating human diseases like cancer, diabetes, and cardiovascular disorders, with a focus on ethical handling and translational applications.Sepsis Research: Investigating biomarkers for early diagnosis and developing therapeutic strategies to combat sepsis.Vascular Pharmacology: Using myography techniques, he explores interventions for vascular diseases and evaluates novel therapeutic targets.

📖Notable Publications

Molecular insights into anti-Protozoal action of natural compounds against
  • Authors : Raish M; Ahmad A; MOHD SHAHNAWAZ KHAN; Kalam MA
  • Journal: biomolecular structure & dynamics
  • Year: 2023
A BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF ULTRASOUND-ASSISTED EXTRACTION OF SINAPIC ACID FROM FRAGARIA ANANASSA
  • Authors : Mudassar Shahid; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N et al.
  • Journal: Pharmaceutical Society
  • Year: 2023
Sinapic acid alleviates 5-fluorouracil-induced nephrotoxicity in rats via Nrf2/HO-1 signalling.
  • Authors : Ahmad Ansari M; Shahid M; Ahmad SF; Ahmad A; Alanazi A; Malik A; Bin Jardan YA; Attia SM; Bakheet SA; Raish M
  • Journal: Pharmaceutical Sciences
  • Year: 2023
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
  • Authors : Zhang, M., Si, S.J., Dai, W.J., Jin, F., Jiang, L.Q.
  • Journal: Pharmaceutical Society
  • Year: 2023
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism.
  • Authors : Mohammad raish; Ahmad A; Mudassar Shahid; Yousef A Bin Jardan; Abdul Ahad; Dr Mohd Abul Kalam; Mushtaq Ahmad Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:Molecules
  • Year: 2023

Dr. ANANDARUP GOSWAMI| Drug Discovery and Developmenty|Best Researcher Award

Dr. ANANDARUP GOSWAMI| Drug Discovery and Development|Best Researcher Award

Dr. ANANDARUP GOSWAMI at Vignan’s Foundation for Science, Technology and Research,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Anandarup Goswami’s passion for chemistry was ignited during his early years of education. He completed his undergraduate studies with a B.Sc. (Hons.) in Chemistry from the prestigious Presidency University in Kolkata, one of India’s top institutions for the sciences. He further honed his expertise by pursuing an M.Sc. in Chemistry at the renowned Indian Institute of Technology (IIT) Kanpur, known for producing some of the finest scientific minds in the country. Dr. Goswami’s dedication to his academic pursuits earned him a place in Cornell University, USA, where he completed his Ph.D. His doctoral work marked the beginning of his contribution to cutting-edge research, where he specialized in advanced areas of chemistry. His journey did not stop there; he went on to complete his postdoctoral research at Rutgers University, USA, and Palacky University, Czech Republic, enhancing his research portfolio and gaining exposure to diverse scientific methodologies and innovative research techniques.

Professional Endeavors 🧪

Dr. Anandarup Goswami joined Vignan’s Foundation for Science, Technology and Research (VFSTR) as an Associate Professor in November 2026. His professional career spans a broad spectrum of roles, from teaching and mentoring students to leading groundbreaking research. He has served as a Ph.D. supervisor and has guided numerous students in drug degradation studies and nanocatalysis development for environmental applications. His work at VFSTR has helped shape the future of young scientists while driving forward critical research in sustainable chemistry.

Dr. Goswami also holds numerous editorial appointments, including being a member of the Editorial Board of Current Indian Science (Bentham) and a Review Editor for Green and Sustainable Chemistry (Frontiers). His contributions to these roles highlight his prominence in the scientific community, where he is trusted to review and oversee publications in these significant areas of research.

Contributions and Research Focus 🔬

Dr. Goswami’s research contributions are primarily centered around two critical areas: pharmaceutically relevant compounds and sustainable nanocatalysts. His extensive work in the isolation and in-depth characterization of degradation products of pharmaceutical compounds has significant implications for drug safety, efficacy, and regulatory science. In tandem, his pioneering work on the development of nanocatalysts for environmental applications addresses pressing issues related to sustainability and environmental protection.

Dr. Goswami’s work emphasizes catalysis, energy conversion, and material science, offering solutions to some of today’s most critical challenges. His contributions span more than 50 peer-reviewed publications, including in highly reputed journals such as Journal of the American Chemical Society (JACS), Angewandte Chemie, and Nature Chemistry. Moreover, his book, Solvent-Free Methods in Nanocatalysis: From Catalyst Design to Applications, co-edited with prominent scientists, reflects his authority in the field of nanocatalysis.

Accolades and Recognition 🏆

Dr. Goswami’s research accomplishments have been widely recognized in the scientific community. With an h-index of 27 on Google Scholar and 26 on Scopus, along with more than 8,800 citations, his work has made a lasting impact on his field. He has received recognition for his contributions to nanocatalysis and drug degradation, and his research has gained international acclaim.

One of his notable patents, US010722743B2, titled Multicatalyst Polyelectrolyte Membranes and Methods of Utilizing the Same, was developed during his time at Rutgers University, USA. This patent reflects his innovative approach to solving complex problems in material science and catalysis.

Dr. Goswami’s contributions have also led him to collaborate with renowned scientists globally, including Prof. Tewodros Asefa from Rutgers University, USA, and Prof. Radek Zboril from RCPTM, Czech Republic. These collaborations have expanded his research’s scope and influence, enabling him to contribute to international advancements in chemistry.

🎓Publication 

Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis

  • Authors   : Manoj B Gawande, Anandarup Goswami, François-Xavier Felpin, Tewodros Asefa, Xiaoxi Huang, Rafael Silva, Xiaoxin Zou, Radek Zboril, Rajender S Varma
  • Journal    :Chemical reviews
  • Year         :2016

obalt‐Embedded Nitrogen‐Rich Carbon Nanotubes Efficiently Catalyze Hydrogen Evolution Reaction at All pH Values

  • Authors   : Xiaoxin Zou, Xiaoxi Huang, Anandarup Goswami, Rafael Silva, Bhaskar R Sathe, Eliška Mikmeková, Tewodros Asefa
  • Journal    :Angewandte Chemie International Edition
  • Year         :2014

Core–shell nanoparticles: synthesis and applications in catalysis and electrocatalysis

  • Authors   : Manoj B Gawande, Anandarup Goswami, Tewodros Asefa, Huizhang Guo, Ankush V Biradar, Dong-Liang Peng, Radek Zboril, Rajender S Varma
  • Journal    :Chemical Society Reviews
  • Year         :2015

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

  • Authors   : Damien Voiry, Anandarup Goswami, Rajesh Kappera, Cecilia de Carvalho Castro e Silva, Daniel Kaplan, Takeshi Fujita, Mingwei Chen, Tewodros Asefa, Manish Chhowalla
  • Journal    :Nature chemistry
  • Year         :2015

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

  • Authors   :Damien Voiry, Anandarup Goswami, Rajesh Kappera, Cecilia de Carvalho Castro e Silva, Daniel Kaplan, Takeshi Fujita, Mingwei Chen, Tewodros Asefa, Manish Chhowalla
  • Journal    :Nature Publishing Group
  • Year         :2015

Assoc Prof Dr. Fatemeh Moradian| Drug Discovery and Development |Best Researcher Award

Assoc Prof Dr. Fatemeh Moradian|Drug Discovery and Development|Best Researcher Award

Assoc Prof Dr. Fatemeh Moradian at Sari Agricultural Sciences and Natural Resources University,Iran

PROFILE  

orcid

 

Early Academic Pursuits 🎓

Fatemeh (Elham) Moradian began her academic journey with a B.Sc. in Biology from the University of Shiraz in 1996. Her passion for biochemistry soon led her to pursue further studies at Tarbiat Modares University, where she earned both her M.Sc. in Biochemistry in 2000 and a Ph.D. in Biochemistry in 2006. Her doctoral research, with its focus on enzymology and the intricate biochemical mechanisms involved in living organisms, set the stage for a prolific academic and research career. During this time, she developed expertise in protein structure and function, which later became a cornerstone of her research.

Professional Endeavors 💼

Following the completion of her Ph.D., Dr. Moradian joined Sari Agricultural Sciences and Natural Resources University (SANRU), where she has been a faculty member from 2006 to 2019. Throughout her tenure, she has taught several advanced courses, including Biochemistry, Enzymology, Biochemistry Mechanisms of Cancer, Animal Cell Culture, and Bioinformatics. Her teaching approach, known for integrating practical applications and research into the curriculum, has shaped many aspiring scientists and biochemists.
Dr. Moradian also had the opportunity to undertake a sabbatical at the University of Alberta in Canada, where she worked at the prestigious Michael James Lab in the Department of Biochemistry. During this 7-month research period (2005-2006), she contributed to a project focused on the structural genomics of Mycobacterium tuberculosis, honing her expertise in microbial biochemistry and structural analysis.

Contributions and Research Focus 🔬

Dr. Moradian’s research interests span a wide array of biochemistry-related fields, but her core focus lies in enzymology, protein purification, cancer research, and microbial biochemistry. Her research on the isolation, purification, and characterization of novel enzymes has made significant contributions to both environmental and medical biotechnology. One of her early landmark studies involved the isolation and characterization of an alkaline protease from Bacillus sp HS-08, which was presented at the International Conference on Environmental, Industrial, and Applied Microbiology in Spain in 2005.

Her research has taken her across the globe, presenting papers at prestigious international conferences in countries like China, France, the Netherlands, and Russia. Her work on thermostable proteases and their resistance to extreme conditions has significant implications for industrial biotechnology, especially in detergent and solvent industries.

One of her notable research projects involved studying the inhibitory effects of silver (Ag) and iron (Fe) colloidal nanoparticles on P. aeruginosa and E. coli growth, presented at the 17th International Conference on Biotechnology and Nanotechnology in Venice, Italy, in 2015. This work highlights her foray into nanotechnology and its biomedical applications, particularly in developing antimicrobial agents.

Accolades and Recognition 🏅

Throughout her career, Dr. Moradian has gained international recognition for her research contributions. She has been invited to present her work at numerous prestigious conferences, where her findings have been well-received by the global scientific community. Her work on cancer research, particularly the cytotoxic effects of caffeic acid extracted from Echinacea purpurea on human gastric cancer cells, has garnered significant attention. Presented at the International Conference on Medical and Health Sciences in Saint Petersburg, Russia, in 2018, this study underscores her commitment to discovering new avenues for cancer treatment using natural compounds.

Additionally, Dr. Moradian’s research on lactoferrin and its antimicrobial and anticancer effects, which she presented at various conferences in Paris and Indonesia, has positioned her as a key contributor to the field of medical biochemistry, particularly in exploring non-invasive treatments for stomach adenocarcinoma.

Impact and Influence 🌍

Dr. Moradian’s contributions have not only advanced scientific knowledge but have also inspired future generations of scientists. Through her teaching and mentorship, she has guided numerous students toward successful careers in biochemistry and biotechnology. Her integration of theoretical knowledge with real-world applications has been particularly influential in shaping her students’ understanding of the critical role biochemistry plays in solving global challenges, from environmental sustainability to cancer treatment.

Her research on thermostable enzymes and antimicrobial nanoparticles continues to have a broad impact on industries ranging from pharmaceuticals to environmental sciences. Additionally, her work on stress responses in plants, particularly the superoxide dismutase activity in salt stress conditions in Aeluropus littoralis, has implications for agricultural biotechnology and improving crop resilience.

Legacy and Future Contributions 🌱

As an established biochemist with a strong research portfolio, Dr. Moradian’s legacy is already well-established in the fields of enzymology, cancer research, and microbial biochemistry. However, her work is far from over. She continues to explore new frontiers in biochemistry, particularly in the areas of cancer therapeutics and environmental biotechnology. With her vast experience and network of international collaborators, Dr. Moradian is poised to make further groundbreaking contributions to science.
Her future projects are expected to delve deeper into understanding the biochemical mechanisms underlying cancer cell resistance and finding novel ways to target them using natural compounds and engineered nanoparticles.

In summary, Dr. Fatemeh Moradian is a biochemist whose career is marked by innovative research, impactful teaching, and a commitment to scientific discovery. Her work continues to inspire and influence both her peers and the next generation of scientists.

🎓Publication 

In vitro study of the expression of autophagy genes ATG101, mTOR and AMPK in breast cancer with treatment of lactoferrin and in silico study of their communication networks and protein interact

  • Authors   :Atefeh Mashhadi Kholerdi; Fatemeh Moradian; Havva Mehralitabar
  • Journal    :Biophysics and Molecular Biology
  • Year         :2024

Identification, Isolation, Cloning, and Expression of a New Alkaline Serine Protease Gene from Native Iranian Bacillus sp. RAM 53 for Use in the Industry

  • Authors   : Aliakbar Alei; Fatemeh Moradian; Ayoub Farhadi; Mehdi Rostami
  • Journal    :Applied Biochemistry and Biotechnology
  • Year         :2023

Nanoencapsulation of oral‐pharmaceutical lactoferrin using chitosan and the evaluation of stability against trypsin and pepsin and its antibacterial effect

  • Authors   :Ijaz, R., Waqas, M., Mahal, A., Alatawi, N.S., Aloui, Z.
  • Journal    :Journal of Molecular Graphics and Modelling,
  • Year         :2024

Rational designing of phenothiazine dioxide based hole transporting materials for efficient perovskite solar cells

  • Authors   : Farzaneh Hedyeloo; Fatemeh Moradian; Mehran Rostami
  • Journal    :Micro & Nano Letters
  • Year         :2023

The effect of lactoferrin on ULK1 and ATG13 genes expression in breast cancer cell line MCF7 and bioinformatics studies of protein interaction between lactoferrin and the autophagy initiation complex

  • Authors   : Zahra Karabi; Fatemeh Moradian; Mitra Kheirabadi
  • Journal    :Cell Biochemistry and Biophysics
  • Year         :2022